Aspirus Portage Clinic is taking significant strides to raise awareness about Type 2 diabetes, a chronic condition that affects over 135 million people in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Alarmingly, one in five adults remains undiagnosed, making proactive education essential.
In an effort to address this growing health concern, Dr. Jill Pogorelec, a Family Medicine Specialist at Aspirus Portage Clinic, will lead a discussion titled “Type 2 Diabetes: Risk Factors and Treatment Options” on Thursday, April 17, from 5:30 p.m. to 6:30 p.m. The event will take place at Aspirus Divine Savior Hospital, located at 2817 New Pinery Road, in the Lower-Level Conference Room A.
The session will cover vital information about the condition, including:
-
Understanding what Type 2 Diabetes is and why timely treatment is critical.
-
Identifying key environmental and lifestyle risk factors contributing to its development.
-
Exploring both non-pharmaceutical and prescription treatment options.
This free event aims not only to educate attendees but also to empower them with actionable knowledge to either prevent or manage Type 2 diabetes. Recognizing the role of lifestyle modifications in prevention and management, Aspirus emphasizes the importance of fostering healthier communities through education and support.
While the event is free, advance registration is recommended. Interested participants can register by calling 608.745.3868, Monday through Friday, from 8 a.m. to 4:30 p.m.
Aspirus continues to demonstrate its commitment to community health by offering accessible resources and expert-led education to help individuals take control of their wellness. Whether you’re managing a diagnosis or simply seeking more information, this event provides an opportunity to connect with healthcare professionals and community members in a supportive environment.
Related topics:
Clinical Trial Explores Osteoporosis Drug for Potential Type 1 Diabetes Treatment
Automated Insulin Delivery System Enhances Glycemic Control in Type 2 Diabetes
Groundbreaking Research Brings New Hope for Diabetes Treatment
